"Anti-Cancer Drugs" is a free public lecture on February 27
A free public lecture titled "Anti-Cancer Drugs: Discovery and Development" will be given on February 27, 2016, by Raymond J. Hohl, a professor of medicine and of pharmacology at Penn State University who also is the director of the Penn State Cancer Institute. The lecture begins at 11:00 a.m. in 100 Thomas Building on the Penn State University Park Campus.
The presentation concludes the series of six lectures on consecutive Saturdays in the 2016 Penn State Lectures on the Frontiers of Science, an annual free public minicourse provided by Penn State's Eberly College of Science. Registration is not required, and all are welcome to attend this lecture. The overall topic of this year's series is "Medical Research from Labs to Hospitals to Homes." Hohl and the other speakers in the 2016 series all are making discoveries at the frontiers of research related to human health.
Hohl's research program targets the discovery and development of novel anticancer therapies. His work ranges from chemistry and basic laboratory studies to innovative clinical trials with human participants. His research has been well-supported by grants from the National Institutes of Health, the Roy J. Carver Charitable Trust, the U.S. Department of Defense, the Leukemia and Lymphoma Society, the American Institute for Cancer Research, and other sources. In addition, he has been a principal investigator for many investigator-initiated clinical trials. He is an inventor for two key patents related to his research and is the co-founder of a biotechnology company that is advancing these discoveries to human therapies.
He has published more than 100 peer-reviewed articles and reviews and 12 book chapters, and he has served as associate editor for the textbook Pharmacology and Therapeutics: Principles to Practice. Hohl is associate editor of the journal Clinical Pharmacology and Therapeutics and he is on the editorial advisory board of the journal Lipids. He also is reviewer for many scientific journals.
He has served in prominent leadership roles in professional groups including the American Society for Clinical Pharmacology and Therapeutics -- as the group's president and also as a member of its board of directors -- and the Iowa Oncology Society -- as its vice president and president. In addition to his research, clinical, and administrative accomplishments, Hohl has extensive experience teaching graduate students, medical students, and other health-sciences students in classroom and clinical settings. His patient care experience spans the breadth of hematology and medical oncology as well as clinical pharmacology.
Hohl received a doctor of medicine degree from Rush Medical College at Rush University, and a doctor of pharmacology degree from Rush University. After completing a residency in internal medicine and a fellowship in hematology/oncology at the University of Chicago, he joined the faculty of the University of Iowa College of Medicine in 1991 as an assistant professor of internal medicine. At Iowa, Hohl held numerous leadership and administrative roles including serving as director of the division of hematology, oncology, and blood & marrow transplantation, and as director of the fellowship program in hematology and oncology. His research leadership roles at the University of Iowa were in both the Holden Comprehensive Cancer Center and the Institute for Clinical and Translational Science. Hohl joined the Penn State University faculty in March 2014 as director of the Penn State Cancer Institute and as professor of medicine and professor of pharmacology.
The Penn State Lectures on the Frontiers of Science is an annual free public minicourse organized and supported by the Penn State Eberly College of Science as an enjoyable and enlightening learning opportunity for residents of the Central Pennsylvania area. The lectures are recorded and archived online for learners worldwide. More information about the Penn State Lectures on the Frontiers of Science, including links to archived recordings of previous lectures, is online at science.psu.edu/frontiers.
For additional information or access assistance, contact the Eberly College of Science Office of Media Relations and Public Information by calling 814-867-5830 or e-mailing email@example.com.
[ J. N. / B. K. K. ]